Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Cerilliant
Harvard Business School
Teva
Merck
AstraZeneca
US Department of Justice
Covington
Cantor Fitzgerald
Moodys

Generated: August 23, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 8,226,610 protect, and when does it expire?


Patent ► Subscribe protects AUVI-Q and EVZIO and is included in three NDAs.

This patent has ninety-eight patent family members in fourteen countries.

Summary for Patent: ► Subscribe

Title:Medical injector with compliance tracking and monitoring
Abstract: A system includes a medicament delivery device and a container configured to receive at least a portion of the medicament delivery device. The medicament delivery device includes an actuator and a first electronic circuit system. The actuator is configured to initiate delivery of a medicament into a body when the actuator is moved from a first position to a second position. The first electronic circuit system is configured to output a first electronic signal when the actuator is moved from the first position to the second position. The container includes a second electronic circuit system configured to receive the first electronic signal. The second electronic circuit system is configured to output a second electronic signal associated with the first electronic signal.
Inventor(s): Edwards; Eric S. (Midlothian, VA), Edwards; Evan T. (Fredericksburg, VA), Licata; Mark J. (Doswell, VA), Meyers; Paul F. (Fishers, IN), Weinzierl; David A. (Andover, MN), Williamson, IV; T. Spencer (Richmond, VA)
Assignee: Intelliject, Inc. (Richmond, VA)
Application Number:12/017,405
Patent Claim Types:
see list of patent claims
Delivery; Device; Dosage form; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Kaleo Inc
AUVI-Q
epinephrine
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-002Aug 10, 2012BXRXYesYes► Subscribe► SubscribeY
Kaleo Inc
AUVI-Q
epinephrine
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-001Aug 10, 2012BXRXYesNo► Subscribe► SubscribeY
Kaleo Inc
EVZIO
naloxone hydrochloride
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS209862-001Oct 19, 2016RXYesYes► Subscribe► SubscribeY
Kaleo Inc
EVZIO
naloxone hydrochloride
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS205787-001Apr 3, 2014RXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: ► Subscribe

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,920,377Devices, systems and methods for medicament delivery► Subscribe
8,105,281Devices, systems and methods for medicament delivery► Subscribe
8,231,573Medicament delivery device having an electronic circuit system► Subscribe
7,947,017Devices, systems and methods for medicament delivery► Subscribe
8,016,788Devices, systems and methods for medicament delivery► Subscribe
9,149,579Devices, systems and methods for medicament delivery► Subscribe
8,690,827Devices, systems, and methods for medicament delivery► Subscribe
7,416,540Devices systems and methods for medicament delivery► Subscribe
8,361,026Apparatus and methods for self-administration of vaccines and other medicaments► Subscribe
8,622,973Simulated medicament delivery device configured to produce an audible output► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Mexico2008012446► Subscribe
United Kingdom201213906► Subscribe
United Kingdom2491283► Subscribe
Hong Kong1123758► Subscribe
Hong Kong1126992► Subscribe
Israel183247► Subscribe
Israel184552► Subscribe
Israel193712► Subscribe
Israel209219► Subscribe
Israel243709► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Accenture
Moodys
Medtronic
Mallinckrodt
Queensland Health
Fuji
US Army
Merck
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot